Real-time enrollment status for this crohn's disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:34 PM UTC
| NCT Number | NCT06456593 |
| Recruiting Status | Recruiting |
| Condition | Crohn's Disease |
| Phase | PHASE2 |
| Target Enrollment | 212 participants |
| Active Locations | 43 sites in the US |
| Sponsor | Abivax S.A. |
| Last Updated on CT.gov | April 27, 2026 (Apr 27, 2026) |
As of July 17, 2026: Clinical trial NCT06456593 is currently recruiting participants. This phase2 study for crohn's disease is actively seeking new participants at 43 locations across the United States. The study is sponsored by Abivax S.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06456593 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06456593 was last updated Apr 27, 2026 (April 27, 2026). HelloStudys verifies this status automatically.